Immunomic Therapeutics Announces Presentation on Nucleic Acid-Based UNITE® Vaccine Platform at Vacci

ROCKVILLE, Md.--(BUSINESS WIRE)--#PowerofUnite--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP-mediated nucleic acid-based immunotherapy announced today that it will present at the Vaccines Summit 2022 at the Sheraton Reston Hotel in Reston,...

Related Keywords

Rockville ,Maryland ,United States ,Wei Shen ,Melissa Kemp ,Sheraton Reston Hotel In ,Powerofunite Immunomic Therapeutics Inc ,Immunomic Therapeutics Inc ,Powerofunite Immunomic Therapeutics ,Vaccines Summit ,Sheraton Reston Hotel ,Vaccine Discovery ,Vaccine Platform Provides Novel Treatment Options ,Unmet Medical Needs ,Infectious Diseases ,Nucleic Acid Based ,Intracellular Targeted Expression ,Lysosomal Associated Membrane Protein ,Immunomic Therapeutics ,